ArticlePDF Available

Radiofrequency catheler ablation of atrioventricular nodal reentry tachycardia: Selective approach to the slow pathway via the superior vena cava

Authors:

Abstract and Figures

Selective radiofrequency catheter ablation of the slow atrioventricular nodal pathway is currently considered the first-line therapy for patients suffering from recurrent symptomatic atrioventricular nodal reentry tachycardia. In most cases slow pathway conduction may be selectively eliminated or modified by the application of radiofrequency current at the posterior portion of Koch's triangle. The ablation site is usually targeted by careful mapping of this area performed using an ablation catheter advanced via the inferior vena cava approach. In this report we describe 2 cases in which the conventional approach to the target site was either impossible owing to the presence of an atresic inferior vena cava (case 1), or contraindicated in view of a history of common femoral vein thrombosis, subsequently extended up to the inferior vena cava (case 2). In both patients a superior vena cava approach was utilized and the slow pathway was successfully ablated. In case of arrhythmias necessitating slow pathway mapping and ablation, such an approach may be considered as a feasible and safe alternative whenever, owing to the presence of anomalies and/or diseases of the inferior vena cava, the conventional approach cannot be employed.
Content may be subject to copyright.
142
Introduction
Radiofrequency catheter modification
or elimination of the slow atrioventricular
nodal pathway is currently considered the
first-line treatment for patients presenting
with recurrent symptomatic atrioventricular
nodal reentry tachycardia (AVNRT)1. The
slow pathway is commonly localized at the
posterior portion of Koch’s triangle2. The ef-
fective ablation site is generally targeted
by careful mapping of this area, accom-
plished using a deflectable catheter ad-
vanced along the inferior vena cava (IVC).
In this report, we describe 2 cases in which
a superior vena cava (SVC) approach was
utilized to successfully ablate the slow path-
way in 2 patients in whom the convention-
al approach to the target site was either im-
possible or contraindicated owing to con-
genital (case 1) and acquired (case 2) disease
of the IVC.
Description of cases
Case 1. A 44-year-old woman was admit-
ted to our hospital for recurrent episodes of
paroxysmal palpitation. A 12-lead ECG,
recorded during an arrhythmic episode,
showed a narrow QRS complex supraven-
tricular tachycardia at a rate of 180 b/min.
P waves were discernible and the RP’ in-
terval was much shorter than the P’R in-
terval. Vagal maneuvers as well as intra-
venous antiarrhythmic drugs administered
in the emergency room had successfully
terminated the arrhythmic attacks, whereas
chronic oral antiarrhythmic therapy was in-
effective in preventing recurrences. The pa-
tient’s past medical history included pleurisy
and appendicectomy at 22 and 36 years of
age respectively. On admission, physical
examination as well as chest X-ray and
transthoracic echocardiography were nor-
mal. A12-lead ECG recorded during sinus
rhythm excluded manifest ventricular pre-
excitation or any other abnormality. Having
© 2001 CEPI Srl
Received October 27,
2000; accepted November
23, 2000.
Address:
Prof. Jorge A. Salerno-Uriarte
Università degli Studi
dell’Insubria-Varese
Dipartimento di
Cardiologia “Mater Domini”
Via Gerenzano, 2
21053 Castellanza (VA)
E-mail: jsalerno@unipv.it
Case reports
Radiofrequency catheter ablation
of atrioventricular nodal reentry tachycardia:
selective approach to the slow pathway
via the superior vena cava
Andrea Avella, Roberto De Ponti, Massimo Tritto, Giammario Spadacini,
Jorge A. Salerno-Uriarte
Department of Cardiology Mater Domini, Castellanza (VA), University of Insubria-Varese, Italy
Selective radiofrequency catheter ablation of the slow atrioventricular nodal pathway is current-
ly considered the first-line therapy for patients suffering from recurrent symptomatic atrioventricu-
lar nodal reentry tachycardia. In most cases slow pathway conduction may be selectively eliminated
or modified by the application of radiofrequency current at the posterior portion of Koch’s triangle.
The ablation site is usually targeted by careful mapping of this area performed using an ablation catheter
advanced via the inferior vena cava approach. In this report we describe 2 cases in which the conventional
approach to the target site was either impossible owing to the presence of an atresic inferior vena ca-
va (case 1), or contraindicated in view of a history of common femoral vein thrombosis, subsequent-
ly extended up to the inferior vena cava (case 2). In both patients a superior vena cava approach was
utilized and the slow pathway was successfully ablated. In case of arrhythmias necessitating slow path-
way mapping and ablation, such an approach may be considered as a feasible and safe alternative when-
ever, owing to the presence of anomalies and/or diseases of the inferior vena cava, the conventional ap-
proach cannot be employed.
(Ital Heart J 2001; 2 (2): 142-146)
Key words:
Superior vena cava;
Supraventricular
tachycardia;
Transcatheter
ablation.
A Avella et al - Superior vena cava approach to slow pathway
obtained written informed consent from the patient, an
off-drug electrophysiologic study was performed in a
fasting nonsedated state. Following local anesthesia
(0.5% bupivacaine), a 6F tetrapolar catheter (Soloist,
Medtronic Puerto Rico, Villalba, PR, USA) was inserted
into the right common femoral vein. While maneu-
vering the catheter under fluoroscopic guidance, the op-
erator failed to advance it directly into the right atrium,
the catheter course resulting posterior to the cardiac sil-
houette, as observed at the left lateral fluoroscopic
view. Further advancement of the catheter permitted
passage beyond the cardiac silhouette and into the
right atrium via the SVC. Subsequently, contrast medi-
um injection into the right and left iliac veins revealed
that the IVC was not present. Passage of the catheter
via a large azygos vein, into the SVC and then into the
right atrium was confirmed. Subsequently, by means of
a long 0.032 inch guide wire, similarly advanced
through the SVC, the inferior part of the right atrium
was probed. No access to the IVC could be found. In
view of this evidence, consistent with infrahepatic
atresia of the IVC, a second 6F tetrapolar catheter
(Soloist, Medtronic) and a 7F bidirectional, deflec-
table mapping/ablation catheter (Stinger F Curve, Bard
Electrophysiology, Lowel, MA, USA) were positioned
in the coronary sinus and at the apex of Koch’s trian-
gle from the right basilic and the left subclavian veins
respectively (Fig. 1A). The ablation catheter deflec-
tability allowed stable recording of the His bundle
electrogram (Fig. 1B).
Baseline electrophysiologic study revealed dual
atrioventricular nodal physiology but excluded the pres-
ence of accessory atrioventricular connections. By pro-
grammed atrial stimulation, a typical AVNRT, with a cy-
cle length of 350 ms, resulted reproducibly inducible
when the antegrade fast pathway effective refractory pe-
riod was reached. Then, by deflecting the ablation
catheter in the opposite direction, the distal electrode was
moved from the His bundle area to the posterior aspect
of Koch’s triangle, where mapping was carefully per-
formed in sinus rhythm. A possible slow pathway po-
tential was located slightly anterior to the coronary si-
nus ostium (Fig. 2). By applying a moderate counter-
clockwise rotation on the ablation catheter, stable con-
tact was achieved. Asingle radiofrequency energy ap-
plication delivered at this site for 30 s, in the tempera-
ture control mode (target temperature 65°C), resulted in
the early occurrence of an accelerated junctional rhythm
(Fig. 3). Subsequently, programmed and incremental atri-
al stimulation showed a continuous atrioventricular
nodal antegrade conduction curve and the absence of any
reentrant arrhythmia, even during isoproterenol infusion.
Ventricular stimulation did not reveal any modification
of the retrograde Wenckebach point. No arrhythmias
were induced. During the follow-up period of 8 months
no arrhythmias recurred, confirming the success of the
procedure.
Case 2. A 74-year-old woman was referred to our hos-
pital because of weekly episodes of sustained sympto-
matic AVNRT, unresponsive to various antiarrhythmic
drugs. Patient history included essential hypertension
lasting 10 years and a hemorrhagic stroke resulting in
143
Figure 1. Panel A: right anterior oblique fluoroscopic view (30°RAO) showing the electrode catheters positioned within the coronary sinus and the mid-
right atrium, from the right subclavian and the azygos veins respectively. The mapping/ablation catheter is positioned in the His bundle region from the
left subclavian vein. AzV = azygos vein; Csos = coronary sinus ostium; HB = His bundle region; LSV = left subclavian vein; RA = right atrium; RSV
= right subclavian vein; SVC = superior vena cava. Panel B: surface ECG leads I, II and III simultaneously recorded with bipolar intracardiac elec-
trograms from the distal and proximal coronary sinus, the right atrium and the His bundle region during sinus rhythm. CSd = distal coronary sinus; CSp
= proximal coronary sinus; HBE = His bundle electrogram; RA = right atrium.
AB
Ital Heart J Vol 2 February 2001
aphasia and right hemiparesis at 72 years of age. Six
months before admission to our hospital, she had un-
dergone an unsuccessful catheter ablation of the slow
atrioventricular nodal pathway at another institution,
complicated by right common femoral vein thrombosis
subsequently extended up to the IVC.
On admission, physical examination did not disclose
any signs of congestive heart failure. A12-lead ECG,
recorded in sinus rhythm, revealed only T wave aspe-
cific abnormalities in the right precordial leads. Chest
X-ray and transthoracic echocardiography were normal.
Owing to the recent thrombotic vasculopathy, it was de-
cided to employ a SVC approach in order to perform
electrophysiologic evaluation. Having obtained written
informed consent from the patient and administered lo-
cal anesthesia (0.5% bupivacaine), a 6F decapolar
catheter (Response, Daig Corporation, Minnetonka,
MN, USA) was inserted into the right basilic vein
and then positioned within the coronary sinus. A 7F
bidirectional deflectable mapping/ablation catheter
(Stinger F Curve, Bard Electrophysiology) was in-
serted into the left subclavian vein and then posi-
tioned across the tricuspid valve. The His bundle elec-
trogram was recorded. Baseline electrophysiologic
evaluation, performed in a fasting nonsedated state,
confirmed dual atrioventricular nodal physiology and
excluded the presence of accessory atrioventricular
pathways. Programmed atrial stimuli, applied at the
mid-coronary sinus, documented the reproducible in-
ducibility of a typical AVNRT, with a cycle length of
390 ms. Then, by deflecting the ablation catheter from
the His position downwards and posteriorly, the pos-
terior aspect of Koch’s triangle was mapped in detail
during sinus rhythm. Apossible slow pathway poten-
tial was localized along the tricuspid annulus imme-
diately anterior to the coronary sinus ostium (Fig. 4).
Whilst maintaining stable contact by applying a coun-
terclockwise torque on the ablation catheter, ra-
diofrequency current in the temperature control mode
(target temperature 65°C) was delivered at this site for
45 s. An active junctional rhythm rapidly ensued. Sub-
sequent electrophysiologic evaluation confirmed suc-
cessful ablation of the slow pathway and demonstrat-
ed the impossibility of inducing any reentrant ar-
rhythmia, even during isoproterenol infusion. No ar-
rhythmia recurrences occurred during the follow-up pe-
riod lasting 3 months.
144
Figure 2. Panel A: right anterior oblique fluoroscopic view (30°RAO) showing the right atrium catheter in a higher position and the bidirectional map-
ping/ablation catheter deflected in the posterior portion of Kochs triangle, where a slow pathway potential is recorded. Abl = slow pathway ablation
site. Panel B: bipolar intracardiac recording, at the target ablation site, showing a slow pathway potential (arrow). Abl = target site electrogram. Oth-
er abbreviations as in figure 1.
Figure 3. An accelerated junctional rhythm occurring 5 s after the on-
set (arrow) of radiofrequency application at the target site. RF on = on-
set of radiofrequency application. Other abbreviations as in figures 1 and
2.
AB
A Avella et al - Superior vena cava approach to slow pathway
Discussion
Selective radiofrequency catheter ablation of the
slow atrioventricular nodal pathway is currently con-
sidered the first-line therapy for all forms of AVNRT3.
In the majority of patients, slow pathway conduction may
be selectively eliminated by applying radiofrequency cur-
rent at the posterior portion of Koch’s triangle2. The dif-
ferent techniques4-7 used to target the effective ablation
site (anatomically guided, electrogram guided and com-
bined techniques) are exclusively performed following
right atrium catheterization achieved via the IVC ap-
proach. In fact this approach is believed to allow for bet-
ter stability of the ablation catheter.
In this report we describe 2 cases in which the con-
ventional approach was either impossible or con-
traindicated, because of the presence of congenital
anomalies (case 1) and acquired diseases (case 2) of the
IVC. The first patient presented with atresia of the IVC,
a rare but generally asymptomatic malformation re-
sulting from failure of the right subcardinal vein branch-
es to join the veins of the primitive liver. In this anom-
aly the postrenal segment of the IVC joins the azygos-
hemiazygos veins and drains into the SVC, whereas
the hepatic veins drain directly into the right atrium8. The
second patient presented with a recent history of throm-
bosis of the IVC, as a late complication of a previous
unsuccessful attempt at slow pathway ablation per-
formed at another institution. In both patients a SVC ap-
proach was utilized to ablate the slow pathway. The use
of a bidirectional deflectable ablation catheter allowed
accurate mapping and stable positioning in both the an-
terior and posterior areas of Koch’s triangle. Thus the
atrioventricular node and His bundle were correctly
localized and precise ablation of the slow atrioventric-
ular nodal pathway was possible. The SVC approach is
commonly employed to ablate the right anteroseptal and
anterior accessory pathways when the IVC approach
does not permit satisfactory catheter stability9,10. Fur-
thermore, this approach has already been employed in
a patient with congenital absence of the IVC11, in whom
a right posteroseptal accessory pathway was success-
fully ablated. Finally, the SVC approach for slow path-
way ablation adopted in these two cases can also be used
in every patient, in whom an IVC filter has been im-
planted for recurrent thromboembolism.
In conclusion, although the transvenous femoral
approach may allow for easier catheter positioning
within the Koch’s triangle and for better stability at the
target site, the SVC route should be considered as a fea-
sible and safe alternative for patients who present with
congenital anomalies and/or acquired diseases of the IVC
and who necessitate mapping and ablation of the slow
pathway.
References
01. ACC/AHA Task Force Report. Guidelines for clinical in-
tracardiac electrophysiological and catheter ablation proce-
dures. J Am Coll Cardiol 1995; 26: 555-73.
02. Haissaguerre M, Jais P, Shah D, et al. Analysis of electro-
physiological activity in Koch’s triangle relevant to ablation
of the slow AV nodal pathway. Pacing Clin Electrophysiol
1997; 20 (Part I): 2470-81.
03. Otomo K, Wang Z, Lazzara R, Jackman WM. Atrioventric-
ular nodal reentrant tachycardia: electrophysiological char-
acteristics of four forms and implication for the reentrant cir-
145
Figure 4. Panel A: right anterior oblique fluoroscopic view (30°RAO) showing the decapolar catheter positioned within the coronary sinus and the bidi-
rectional mapping/ablation catheter deflected in the posterior portion of Kochs triangle. Abl = slow pathway ablation site; IVC = inferior vena cava.
Panel B: surface ECG leads I, II, III, V1and V5simultaneously recorded with bipolar intracardiac electrograms from the decapolar coronary sinus catheter
and the mapping/ablation catheter, during sinus rhythm. CS1 to CS5 indicates distal to proximal coronary sinus electrode pairs. Abl = target site elec-
trogram showing slow pathway potential (arrow). Other abbreviations as in figure 1.
AB
Ital Heart J Vol 2 February 2001
cuit. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology:
from cell to bedside. 3rd edition. Philadelphia, PA: WB
Saunders, 2000: 504-21.
04. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment
of supraventricular tachycardia due to atrioventricular nodal
reentry by radiofrequency catheter ablation of slow path-
way conduction. N Engl J Med 1992; 327: 313-8.
05. Jazayeri MR, Hempe SL, Sra JS, et al. Selective transcatheter
ablation of the fast and slow pathways using radiofrequen-
cy energy in patients with atrioventricular nodal reentrant
tachycardia. Circulation 1992; 85: 1318-28.
06. Haissaguerre M, Gaita F, Fischer B, et al. Elimination of atrio-
ventricular nodal reentrant tachycardia using discrete slow po-
tentials to guide application of radiofrequency energy. Cir-
culation 1992; 85: 2162-75.
07. Willems S, Shenasa H, Kottkamp H, et al. Temperature-con-
trolled slow pathway ablation for treatment of atrioventric-
ular nodal reentrant tachycardia using a combined anatomi-
cal and electrogram guided strategy. Eur Heart J 1996; 17:
1092-102.
08. Mayo J, Gray R, St Louis E, Grosman H, McLoughlin M,
Wise D. Anomalies of the inferior vena cava. AJR Am J
Roentgenol 1983; 140: 339-45.
09. Schluter M, Kuch H. Catheter ablation from right atrium of
anteroseptal accessory pathways using radiofrequency cur-
rent. J Am Coll Cardiol 1992; 19: 663-70.
10. Zhu DWX. Radiofrequency catheter ablative therapy for an-
teroseptal and midseptal accessory atrioventricular path-
ways. In: Singer I, ed. Interventional electrophysiology. Bal-
timore, MD: Williams & Wilkins, 1997: 253-73.
11. Inama G, Vergara G, Gramegna L, Rillo M, Fuochi C,
Furlanello F. Catheter ablation of Wolff-Parkinson-White
syndrome associated with congenital absence of inferior ve-
na cava. J Interv Card Electrophysiol 1998; 2: 301-4.
146
... An alternative venous approach for the ablation via right subclavian or right internal jugular vein has been described [6][7][8][9]. Salem et al [9] reported a case series of slow pathway ablation via right internal jugular vein approach in patients with IVC filter. ...
... The number of RF applications required for successful ablation was also relatively high in their case series. Successful slow pathway ablation via subclavian approach has also been described [6][7][8]. ...
Article
Full-text available
Curative radiofrequency catheter modification of the slow pathway is the recommended therapy for patients suffering from recurrent symptomatic atrioventricular nodal reentry tachycardia. This is usually performed via femoral vein and the inferior vena cava (IVC). Presence of venous occlusion or complex venous anomaly involving the IVC may preclude this approach. Here, we report a case with a complex venous anomaly involving the inferior vena cava, who underwent electrophysiological study and successful radiofrequency ablation by an alternative approach.
... Some authors reported successful ablation procedures of atrioventricular nodal reentrant tachycardia (AVNRT) in other similar types of IVC anomalies using a right jugular venous access. [8][9][10] However, in our case, we decided to not perform immediately a similar approach given the high probability of a suboptimal result for a complex unplanned catheter ablation. For such reason, we performed an electrical cardioversion and in the case of AF recurrence we will evaluate a percutaneous approach from the right jugular/subclavian vein, an "ablate and pace" approach or a thoracoscopic AF ablation. ...
Article
Full-text available
The valve of superior caval vein (SCV) is seldom detected and reported. With the increasing popularity of cardiac interventional procedures, it should be paid more attention rather than ignored in clinical practice. Here, we presented a case of the SCV valve detected by transthoracic echocardiography, which was first shown as a valvular structure at the top of the right atrium and ultimately found to be located at the orifice of SCV. And the identification of the valve of SCV will undoubtedly be helpful for risk aversion in future cardiac interventional procedures.
Article
Background Transfemoral venous access (TFV) is the cornerstone of minimally invasive cardiac procedures. Although the presence of inferior vena cava filters (IVCF) was considered a relative contraindication to TFV procedures, small experiences have suggested safety. We conducted a systematic review of the available literature on cardiac procedural success of TFV with IVCF in‐situ. Methods Two independent reviewers searched PubMed, EMBASE, SCOPUS and Google Scholar from inception to October 2020 for studies that reported outcomes in patients with IVCFs undergoing TFV for invasive cardiac procedures. We investigated a primary outcome of acute procedural success and reviewed the pooled data for patient demographics, procedural complications, types of IVCF, IVCF dwell time and procedural specifics. Results Of the 120 studies initially screened, 8 studies were used in the final analysis with a total of 100 patients who underwent 110 procedures. The most common IVCF was the Greenfield Filter (36%), 60% of patients were males and the mean age was 67.8 years. The overall pooled incidence of acute procedural success was 95.45% (95% confidence interval 89.54. ‐ 98.1) with no heterogeneity (I2 = 0%, p = 1) and there were no reported filter related complications. Conclusion This systematic review is the largest study of its kind to demonstrate the safety and feasibility of TFV access in a variety of cardiac procedures in the presence of IVCF. This article is protected by copyright. All rights reserved.
Article
Wenn ein transfemoraler Zugang im Rahmen von Katheterablationsprozeduren paroxysmaler supraventrikulärer Tachykardien nicht zur Verfügung steht, müssen alternative Zugangswege in Betracht gezogen werden. Wir präsentieren den Fall einer 78-jährigen Patientin mit Vena cava inferior (VCI)-Filter und rezidivierenden symptomatischen AV-Knoten-Reentry-Tachykardien (AVNRT). Über einen Zugang per Vena mediana cubiti und Vena axillaris konnte die Tachykardie erfolgreich und komplikationslos abladiert werden.
Chapter
Radiofrequency catheter ablation is a safe and effective treatment for curing supraventricular tachycardias (SVT), including those related to different forms of atrioventricular (AV) nodal reentry and to the Wolff-Parkinson-White syndrome. Although this treatment is largely considered as a first-line therapy for these tachycardias, under some circumstances the safety and/or the effectiveness of the procedure might be endangered. This review will focus on the difficulties that can be met during SVT catheter ablations, and on the role of special tools and new technologies in improving the success rate and reducing the complications.
Article
Background: To compare the feasibility and efficiency of atrioventricular junction (AVJ) ablation and device implantation in patients with drug-refractory atrial fibrillation using three different approaches. Methods: Sixty-nine patients (57% male; age 72 ± 10; ejection fraction 45 ± 15%) undergoing device implantation and AVJ ablation were retrospectively studied at a tertiary referral center. In 20 patients (29%) AVJ ablation was performed via the femoral vein immediately following device implantation (group 1), whereas 33 patients (48%) underwent a staged procedure with AVJ ablation via the femoral vein >3 weeks after device implantation (group 2). In a third group of 16 patients (23%), AVJ ablation was performed during device implantation through the pocket using the same axillary vein access site (group 3). The main outcome measures were: procedure time, fluoroscopy time, laboratory occupancy time, and success rate. Results: There was a significant difference in procedure time (118 ± 45 minutes. in group 1, 133 ± 32 minutes in group 2, and 87 ± 26 minutes in group 3, P < 0.001) and the laboratory occupancy time (175 ± 48 minutes in group 1, 200 ± 32 minutes in group 2, and 121 ± 27 minutes in group 3, P < 0.001). There was no difference in fluoroscopy time (group 1: 20 ± 15 minutes, group 2: 27 ± 22 minutes, and group 3: 24 ± 9 minutes P = 0.4). The procedure was successfully completed in all patients, but cross-over to a femoral approach was required in one patient in group 3. Conclusion: The alternative approach of AVJ ablation during permanent pacemaker implantation from the same axillary vein access site is feasible and more efficient compared to the femoral approach.
Article
Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common supraventricular tachycardia. Ablation of the slow pathway is the treatment of choice for recurrent episodes despite adequate medical therapy. We present an uncommon case of AVNRT ablation using a superior vena cava approach in a patient with bilateral common femoral vein occlusion. This approach appears to be a safe alternative in patients with an absence of an inferior venous access. ©2011, The Authors. Journal compilation
Article
Inferior venous access to the right heart is not possible in some patients due to vena caval obstruction. Here we describe a case of a patient with atrioventricular nodal re-entry tachycardia where radiofrequency ablation from the inferior vena cava was impossible because of the presence of important stenosis of the distal part of the vein. Catheter ablation of the slow pathway could be performed successfully using a superior approach via the cephalic veins.
Article
Full-text available
Atrioventricular nodal reentrant tachycardia (AVNRT), the most common form of supraventricular tachycardia, results from conduction through a reentrant circuit comprising fast and slow atrioventricular nodal pathways. Antiarrhythmic-drug therapy is not consistently successful in controlling this rhythm disturbance. Catheter ablation of the fast pathway with radiofrequency current eliminates AVNRT, but it can produce heart block. We hypothesized that catheter ablation of the site of insertion of the slow pathway into the atrium would eliminate AVNRT while leaving normal (fast-pathway) atrioventricular nodal conduction intact. Eighty patients with symptomatic AVNRT were studied. Retrograde slow-pathway conduction (in which the earliest retrograde atrial potential was recorded at the posterior septum, close to the coronary sinus) was present in 33 patients. The retrograde atrial potential was preceded by a potential consistent with activation of the atrial end of the slow pathway (ASP). In 46 of the 47 patients without retrograde slow-pathway conduction, a potential with the same characteristics as the ASP potential was recorded during sinus rhythm. Radiofrequency current delivered through a catheter to the ASP site (in the posteroseptal right atrium or coronary sinus) abolished or modified slow-pathway conduction in 78 patients, eliminating AVNRT without affecting normal atrioventricular nodal conduction. In the single patient without ASP, the application of radiofrequency current to the proximal coronary sinus ablated the fast pathway and AVNRT: Atrioventricular block occurred in one patient (1.3 percent) with left bundle-branch block, after inadvertent ablation of the right bundle branch. AVNRT has not recurred in any patient during a mean (+/- SD) follow-up of 15.5 +/- 11.3 months. Electrophysiologic study 4.3 +/- 3.3 months after ablation in 32 patients demonstrated normal atrioventricular nodal conduction without AVNRT: Catheter ablation of the atrial end of the slow pathway using radiofrequency current, guided by ASP potentials, can eliminate AVNRT with very little risk of atrioventricular block.
Article
Full-text available
Anatomical and electrogram-guided techniques have been used separately for slow pathway ablation in atrioventricular nodal reentrant tachycardia. The aims of the present study were to analyse electrogram characteristics of target sites and biophysical parameters using a combined anatomical and electrogram-guided technique for temperature-controlled radiofrequency catheter ablation of the slow pathway. Using a temperature-controlled (pre-selected 60 degrees C) catheter system, 53 patients with atrioventricular nodal reentrant tachycardia underwent slow pathway radiofrequency ablation. Mapping was started posteroseptally near the coronary sinus ostium and continued towards the midseptal area if needed. The longest and latest atrial electrograms with an atrioventricular ratio of < or = 0.5 were targeted. After a median of two pulses (mean 2.36 +/- 1.33), atrioventricular nodal reentrant tachycardia was rendered non-inducible in all patients without complications. Successful sites had longer atrial electrograms (78.8 +/- 9.8 vs 67.6 +/- 13.3 ms, P < 0.003) and larger ventricular electrogram amplitudes (92.4 +/- 51.2 vs 63.1 +/- 28.8 mV, P < 0.05) than the failed sites, but had a similar atrioventricular ratio, P-A interval and atrial electrogram amplitude. Overall, an atrial electrogram duration of > or = 70 ms was associated with effective radiofrequency delivery, with 86% sensitivity and 62% specificity. The achieved temperature maximum was 62.3 +/- 9.8 degrees C at successful and 58.8 +/- 9.0 degrees C at unsuccessful sites (ns). There was no significant difference between successful and unsuccessful applications with respect to power output, impedance and total delivery energy. During a pre-discharge study, three patients with inducible atrioventricular nodal reentrant tachycardia underwent a repeat ablation. During 12.3 +/- 2.5 (6-15) months of follow-up, three others had a clinical recurrence of atrioventricular nodal reentrant tachycardia. The combined approach for slow pathway ablation is highly effective, requiring a low number of radiofrequency pulses. Long atrial activation time seems to be the most powerful predictor of success. Similar catheter tip temperature levels during successful and unsuccessful radiofrequency applications indicate that suboptimal selection of target sites rather than ineffective heating due to poor catheter tissue coupling is responsible for unsuccessful energy delivery.
Article
Atrioventricuiar junctional reentrant tachycardia (AVfBT) is the most common form of paroxysmal regular supraventricular tachycardia. In patients with disabling, drug refractory AVJBT, catheter ablation has evolved rapidly from a last-resort treatment in the form of interruption of atrioventricular (AV) conduction to selective modification of AV nodal function as an ideal treatment. This article will focus on the frequently unappreciated electrophysiological activities recordable in man in Kach's triangle during ablation of the so-called slow pathway.
Article
In the present report we describe a patient (a 36-year-old woman with 15 year history of supraventricular tachyarrhythmias) with congenital absence of inferior vena cava (IVC) revealed during radiofrequency (RF) catheter ablation procedure for right postero-septal Wolff-Parkinson-White syndrome (WPW). For the absence of IVC, the ablation procedure was more difficult, because we had to perform the ablation with the catheters (the ablator catheter and the coronary sinus catheter) introduced both through the superior vena cava. The application of RF energy (35 Watt for 60 seconds) at successful site abolished accessory pathway conduction. The following day was performed the venous angiography, showing the absence of the IVC and a venous return via paravertebral venous plexus to the azygous vein and superior vena cava into the right atrium. Computer tomography confirmed the absence of the IVC with azygous continuation. The drainage via the azygous system modified the radiological image on chest roentgenogram of the right mediastinal silhouette. During cardiogenesis fusion of the IVC and organisation of the heart occur between the 33rd to 40th embryonic days. It is therefore possible that some unknown teratogenic mechanism at this critical period might have caused, in the patient, both the developmental arrest of IVC and failure of regression of atrio-ventricular anatomical and electrical continuity in the right postero-septal region.
Article
Catheter ablation with radiofrequency current has recently been introduced as a therapeutic regimen for symptomatic patients with the Wolff-Parkinson-White syndrome or atrioventricular (AV) tachycardia mediated by a retrogradely conducting (concealed) accessory AV pathway. These pathways may be located, although infrequently, in the anteroseptal region of the heart in close proximity to the AV node-His bundle conduction system. Any attempt to interrupt an anteroseptal accessory pathway therefore is subject to the potential complication of inadvertent impairment of normal AV conduction. This study was conducted to establish whether abolition of anteroseptal accessory pathways by radiofrequency current aimed at the atrial as opposed to the ventricular insertion of the pathway can be achieved with preservation of AV node-His bundle conduction.Twelve patients (mean age 37 ± 13 years; 10 with Wolff-Parkinson-White syndrome, 2 with a concealed accessory pathway) were studied. In the majority of patients, radiofrequency current (500 kHz; mean energy 577 ± 207 J) was applied through a steerable catheter with a long tip electrode placed in the anterior septal space at the atrial aspect of the tricuspid anulus, with the intention to destroy the atrial insertion of the accessory pathway. All pathways were successfully ablated. The AV node or His bundle conduction was not impaired in any patient. Right bundle branch block was induced in two patients (17%). There were no complications related to the procedure.It is concluded that catheter ablation from the right atrium using radiofrequency current provides effective and safe interruption of anteroseptal accessory pathways with good preservation of the normal conduction system.
Article
The safety and efficacy of selective fast versus slow pathway ablation using radiofrequency energy and a transcatheter technique in patients with atrioventricular nodal reentrant tachycardia (AVNRT) were evaluated. Forty-nine consecutive patients with symptomatic AVNRT were included. There were 37 women and 12 men (mean age, 43 +/- 20 years). The first 16 patients underwent a fast pathway ablation with radiofrequency current applied in the anterior/superior aspect of the tricuspid annulus. The remaining 33 patients initially had their slow pathway targeted at the posterior/inferior aspect of the right interatrial septum. The fast pathway was successfully ablated in the initial 16 patients and in three additional patients after an unsuccessful slow pathway ablation. A mean of 10 +/- 8 radiofrequency pulses were delivered; the last (successful) pulse was at a power of 24 +/- 7 W for a duration of 22 +/- 15 seconds. Four of these 19 patients developed complete atrioventricular (AV) block. In the remaining 15 patients, the post-ablation atrio-His intervals prolonged from 89 +/- 30 to 138 +/- 43 msec (p less than 0.001), whereas the shortest 1:1 AV conduction and effective refractory period of the AV node remained unchanged. Ten patients lost their ventriculoatrial (VA) conduction, and the other five had a significant prolongation of the shortest cycle length of 1:1 VA conduction (280 +/- 35 versus 468 +/- 30 msec, p less than 0.0001). Slow pathway ablation was attempted initially in 33 patients and in another two who developed uncommon AVNRT after successful fast pathway ablation. Of these 35 patients, 32 had no AVNRT inducible after 6 +/- 4 radiofrequency pulses with the last (successful) pulse given at a power of 36 +/- 12 W for a duration of 35 +/- 15 seconds. After successful slow pathway ablation, the shortest cycle length of 1:1 AV conduction prolonged from 295 +/- 44 to 332 +/- 66 msec (p less than 0.0005), the AV nodal effective refractory period increased from 232 +/- 36 to 281 +/- 61 msec (p less than 0.0001), and the atrio-His interval as well as the shortest cycle length of 1:1 VA conduction remained unchanged. No patients developed AV block. Among the last 33 patients who underwent a slow pathway ablation as the initial attempt and a fast pathway ablation only when the former failed, 32 (97%) had successful AVNRT abolition with intact AV conduction. During a mean follow-up of 6.5 +/- 3.0 months, none of the 49 patients had recurrent tachycardia. Forty patients had repeat electrophysiological studies 4-8 weeks after their successful ablation, and AVNRT could not be induced in 39 patients. These data suggest that both fast and slow pathways can be selectively ablated for control of AVNRT: Slow pathway ablation, however, by obviating the risk of AV block, appears to be safer and should be considered as the first approach.
Article
Ablation of the slow pathway has been performed to eliminate atrioventricular (AV) nodal reentrant tachycardia (AVNRT) either by a surgical approach or by using radiofrequency catheter technique guided by retrograde slow pathway activation mapping. From previous experience of midseptal and posteroseptal mapping, we were aware of the existence of peculiar slow potentials in most humans. Postulating their role in AVNRT, we studied these potentials and the effects of radiofrequency energy. Sixty-four patients (mean age, 48 +/- 19 years) with the usual form of AVNRT were studied. Slow, low-amplitude potentials were recorded when using the anterograde AV conducting system. Slow potentials occupied all (giving a continuum of electrograms) or some of the time between the atrial and ventricular electrograms. Their most specific patterns were their progressive response to increasing atrial rates, which resulted in a dramatic decline in amplitude and slope, a corresponding increase in duration, and a separation from preceding atrial potentials until the disappearance of any consistent activity. Slow potentials were recorded along a vertical band at the mid or posterior part of the septum near the tricuspid annulus. Radiofrequency energy applied at the slow potential site resulted in interruption of induced tachycardia within a few seconds and rendered tachycardia noninducible in all patients. A median of two impulses was delivered to each patient. In 69% of patients, postablation atrial stimulation cannot achieve a long atrial-His interval, which previously was critical for tachycardia induction or maintenance. No patient had AVNRT over a follow-up period of 1-16 months, and all had preserved AV conduction. In all except two patients, the PR interval was unchanged. In 47 patients, long-term electrophysiological studies confirmed the efficacy of ablation and the nonreversibility of results by isoproterenol; however, echo beats remained inducible in 40% of patients. An area showing slow potentials is present at the perinodal region in humans. In patients with AVNRT, application of radiofrequency energy renders tachycardia noninducible through the preferential modification of the anterograde slow pathway. With present clinical methods, the exact origin and significance of these physiological potentials cannot be specified.